FCRL family genes have been found to be strongly positively correlated with tumor-infiltrating lymphocytes (TILs), immunostimulators, and immunoinhibitors in pan-cancer, indicating their significant role in cancer immunomodulation. This evidence concerns the gene FCRLA and cancer.